Skip to main content

Table 1 Clinical characteristics and laboratory findings of the study population

From: Platelet/lymphocyte ratio and mean platelet volume in patients with granulomatosis with polyangiitis

 

GPA patients

Controls

p

Age mean ± SD (years)

48.14 ± 14.09

46.77 ± 14.14

0.614

Males (n)

33 (58.9%)

26 (49.1%)

0.301

WBC (×  103/mL)

11.600 (3.240; 35.490; 6.907)

7.040 (4.100; 11.870; 2.413)

< 0.001

Neutrophils (× 103/mL)

8.230 (1.300; 33.420; 6.830)

4000 (2.300; 11.870; 1.525)

< 0.001

Lymphocytes (× 103/mL)

1.665 (0.300; 5.550; 0.951)

2.320 (1.270; 4.090; 0.690)

< 0.001

Platelets (× 103/mL)

308.000 (82.600; 1126.000; 191.500)

224.600 (136.000; 373.900; 73.600)

< 0.001

ESR (mm/H)

47.5 (3; 131; 60)

8 (1; 34; 7.50)

< 0.001

CRP (mg/L)

34 (1.27; 300; 99.14)

3.1 (1.16; 7.40; 2.07)

< 0.001

MPV

7.54 (6.08; 10.38; 1.29)

8.62 (6.88; 13.10; 1.41)

< 0.001

PLR

212.65 (29.86; 1638.33; 159.62)

101.43 (58.37; 210.63; 35.44)

< 0.001

Creatinine (mg/dL)

0.912 (0.45; 19.90; 1)

0.79 (0.53; 1.12; 0.24)

0.002

GFR

83.50 (2.70; 141.0; 75.25)

99.70 (65.30; 130.70; 21.30)

0.003

  1. Values are presented as median (min; max; interquartile range). GPA Granulomatosis with polyangiitis, WBC white blood cell, ESR erythrocyte sedimentation rate, CRP C-reactive protein, MPV mean platelet volume, PLR platelet/lymphocyte ratio, GFR glomerular filtration ratio